Strongbridge Biopharma plc — Form D

Strongbridge Biopharma plc of TREVOSE, PA, a company, filed a Form D exempt-offering notice with the SEC on 2016-12-30. The offering totals $35.0M, of which $35.0M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
John H JohnsonDirectorBranchburg, NJ
Richard H KollenderDirectorTrevose, PA
Garheng H KongDirectorSeattle, WA
Matthew PaulsDirectorDurham, NC
Jeffrey W ShermanDirectorTrevose, PA
Marten H SteenDirectorTrevose, PA
Hilde H SteinegerDirectorTrevose, PA
Fredric Brian CohenExecutive OfficerTrevose, PA
A. Brian DavisExecutive OfficerTrevose, PA
Stephen Brian LongExecutive OfficerTrevose, PA
Robert Brian LutzExecutive OfficerTrevose, PA
Matthew PaulsExecutive OfficerDurham, NC
BRIAN DAVISExecutive OfficerGRAFTON, WI
A. Brian DavisExecutive OfficerWinston-Salem, NC
Robert LutzExecutive OfficerWoodinville, WA
Stephen LongExecutive OfficerSan Francisco, CA
Joseph M MahadyDirectorWarrington, PA
Steve LongExecutive OfficerOklahoma City, OK
H. Joseph ReiserDirectorVillanova, PA
Ruth Thieroff-EkerdtExecutive OfficerNew York, NY
Eigil Stray SpetalenDirectorTrevose, PA
Ernest Tidemann Eichenberg IIIDirectorRadnor, PA
Alexander LindstromExecutive OfficerRadnor, PA
Espen Tidemann JorgensenDirectorRadnor, PA
Marten Tidemann SteenDirectorRadnor, PA

Other filings by this issuer (3)

FiledFormOfferingSold
2015-09-14D$126.0M$126.0M
2015-07-17D$33.2M$33.2M
2015-02-25D$26.4M$26.4M

More